Search Results - "Baringo, Teresa"

RIT with ^(90)Y-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution by Campos, Marcio Miguel Andrade, Limon, Anel E. Montes, Grasa, Jose Maria, Lievano, Paola, Baringo, Teresa, Giraldo, Pilar

Get full text

90Y-Ibritumomab-Tiuxetan Consolidation in First-Line Complete Response Follicular Lymphoma Patients. Single Center Outcomes Analysis after Five Years Median Follow-up by Andrade-Campos, Marcio, Espinosa-Lara, Natalia, Lievano, Paola, Lopez-Gomez, Luis, Baringo, Teresa, Giraldo, Pilar

“…Introduction: Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma accounting for around 22% of them. Their natural history is characterized…”
Get full text

RIT with 90Y Ibritumomab Tiuxetan in Patients with Non-Hodgkin Lymphoma Over 65 Years by Andrade, Marcio M, Montes, Anel, Murillo, Ilda, Grasa, Jose M, Baringo, Teresa, Giraldo, Pilar

“…Abstract 2742 90Y Ibritumomab tiuxetan (90Y-IT) has become an efficient alternative to therapy in non-Hodgkin Lymphoma, mainly in elderly patients. The aim of…”
Get full text

RIT with 90Y Ibritumomab Tiuxetan in Agressive Non-Hodgkin Lymphoma. Evaluation of Recent Outcomes in a Single Institution by Montes, Anel, Andrade, Ma, Murillo, Ilda, Lopez-Gomez, Luis, Baringo, Teresa, Giraldo, Pilar

“…Abstract 4883 Diffuse Large B Cell (DLBC) and Mantle Cell Lymphoma (MCL), are two subtypes of aggressive non-Hodgkin lymphoma (A-NHL),that frequently present…”
Get full text

Long-term complication in follicular lymphoma: assessing the risk of secondary neoplasm in 242 patients treated or not with 90-yttrium-ibritumomab-tiuxetan by Andrade-Campos, Marcio Miguel, Liévano, Paola, Espinosa-Lara, Natalia, Soro-Alcubierre, Gloria, Grasa-Ulrich, José María, López-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…Background Non‐Hodgkin lymphoma patients have a 25% increased risk of secondary primary neoplasms (SPNs). Regarding the controversy about the increased risk of…”
Get full text

Long-term efficacy of (90)Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life by Andrade-Campos, Marcio Miguel, Montes-Limón, Anel E, Soro-Alcubierre, Gloria, Grasa, José María, Lopez-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…The aim of this study was to analyze the outcomes of 37 follicular lymphoma (FL) patients treated with (90)ytrium ibritumomab tiuxetan (90Y-IT), outside of…”
Get full text

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With 90Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience by Andrade-Campos, Marcio M., Montes-Limón, Anel E., Soro-Alcubierre, Gloria, Lievano, Paola, López-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…Radioimmunotherapy in B-cell malignances is currently recommended as consolidation and salvage therapy, depending on the lymphoma subtype. However, the major…”
Get full text

Long-term efficacy of ^sup 90^Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life by Andrade-campos, Marcio Miguel, Montes-limón, Anel E, Soro-alcubierre, Gloria, Grasa, José María, Lopez-gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…The aim of this study was to analyze the outcomes of 37 follicular lymphoma (FL) patients treated with ^sup 90^ytrium ibritumomab tiuxetan (90Y-IT), outside of…”
Get full text

Long-term efficacy of 90Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life by Andrade-Campos, Marcio Miguel, Montes-Limón, Anel E., Soro-Alcubierre, Gloria, Grasa, José María, Lopez-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…The aim of this study was to analyze the outcomes of 37 follicular lymphoma (FL) patients treated with 90 ytrium ibritumomab tiuxetan (90Y-IT), outside of…”
Get full text

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With90 Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience by Andrade-Campos, Marcio M, Montes-Limón, Anel E, Soro-Alcubierre, Gloria, Lievano, Paola, López-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…Micro-Abstract Radioimmunotherapy in B-cell malignances is currently recommended as consolidation and salvage therapy, depending on the lymphoma subtype…”
Get full text

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With (90)Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience by Andrade-Campos, Marcio M, Montes-Limón, Anel E, Soro-Alcubierre, Gloria, Lievano, Paola, López-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…The mean age of patients included in clinical trials does not reflect the current clinical practice for patients with B-cell non-Hodgkin lymphoma (B-NHL). We…”
Get full text

Tumoural denervation of the nigrostriatal pathway by Añaños, Martin Victor, Baringo, Teresa, Lievano, Paola, De la Cueva, Leticia, Navarro, Pablo, Arroyo, Estela, Gonzalez, Mario, Abos, Dolores

Get full text

RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma : Evaluation of Recent Outcomes in a Single Institution by Andrade Campos, Marcio Miguel, Montes Limón, Anel E., Grasa, Jose María, Lievano, Paola, Baringo, Teresa, Giraldo, Pilar

“…Background. Based on historical data we reviewed our hospital clinical database to analyse our updated information and therapy outcomes of follicular…”
Get full text

Quality Analysis of a Multidisciplinary Program Project in Radioimmunotherapy by Recasens, Valle, Rubio-Martinez, Araceli, Agustin, Maria J., Lopez, Carlos, Galego, Teresa, Ciria, Maria J., Rubio-Escuin, Rebeca, Baringo, Teresa, Giraldo, Pilar

“…Aims: Ibritumomab tiuxetan 90Y (90Y-IT) is an effective therapy for Follicular non Hodgkin Lymphoma (F-NHL), and besides is safe and well tolerated in…”
Get full text

SPECT Scan in Somatization Disorder Patients: An Exploratory Study of Eleven Cases by Garcia-Campayo, Javier, Sanz-Carrillo, Concepcion, Baringo, Teresa, Ceballos, Concepción

“…Objective: There are no previous studies using single photon emission computed tomography (SPECT) scans in somatization disorder (SD) patients. The aim of this…”
Get full text